Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.

MLA

Muhindo, Mary K., et al. “Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine and Risk of Malaria Following Cessation in Young Ugandan Children: A Double-Blind, Randomised, Controlled Trial.” The Lancet. Infectious Diseases, vol. 19, no. 9, Sept. 2019, pp. 962–72. EBSCOhost, https://doi.org/10.1016/S1473-3099(19)30299-3.

APA

Muhindo, M. K., Jagannathan, P., Kakuru, A., Opira, B., Olwoch, P., Okiring, J., Nalugo, N., Clark, T. D., Ruel, T., Charlebois, E., Feeney, M. E., Havlir, D. V., Dorsey, G., & Kamya, M. R. (2019). Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. The Lancet. Infectious Diseases, 19(9), 962–972. https://doi.org/10.1016/S1473-3099(19)30299-3

Chicago

Muhindo, Mary K, Prasanna Jagannathan, Abel Kakuru, Bishop Opira, Peter Olwoch, Jaffer Okiring, Noeline Nalugo, et al. 2019. “Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine and Risk of Malaria Following Cessation in Young Ugandan Children: A Double-Blind, Randomised, Controlled Trial.” The Lancet. Infectious Diseases 19 (9): 962–72. doi:10.1016/S1473-3099(19)30299-3.